Concepedia

Publication | Closed Access

The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines.

43

Citations

14

References

2011

Year

Vivian Arrias Herrera, Evelyn Zeindl‐Eberhart, Andreas Jung, Rudolf M. Huber, Albrecht Bergner
PubMed

Abstract

The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines and a promising compound to be tested in clinical phase I studies.

References

YearCitations

Page 1